KATHERINE PETERSEN: Open Payments
NPI 1720705957 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$694 in 28 payments from 9 companies in 2025. Trend: 2023 $336 · 2024 $459 · 2025 $694
Food & beverage: $678Travel & lodging: $16
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 3 | $181 |
| Lilly USA, LLC | 10 | $181 |
| Amgen Inc. | 4 | $105 |
| Regeneron Healthcare Solutions, Inc. | 2 | $65 |
| PFIZER INC. | 3 | $59 |
| Galderma Laboratories, L.P. | 2 | $41 |
| ABBVIE INC. | 2 | $29 |
| Janssen Biotech, Inc. | 1 | $17 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
Products named: DUPIXENT, OTEZLA, TALTZ, EUCRISA, SKYRIZI, CIBINQO, NEMLUVIO, TREMFYA.
Industry payments across IL — which companies pay providers there.
